JOHN HOPE FRANKLIN CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 5K

Market Cap: -

Website: http://www.duke.edu

Clinical Trials

Biological Therapy in Treating Patients With Metastatic Cancer

Phase 1

Completed

Conditions: Breast Cancer
Colorectal Cancer
Extrahepatic Bile Duct Cancer
Gallbladder Cancer
Gastric Cancer
Head and Neck Cancer
Liver Cancer
Lung Cancer
Metastatic Cancer
Ovarian Cancer

Interventions: Biological: CEA RNA-pulsed DC cancer vaccine

First Posted Date: 2004-04-28

Last Posted Date: 2013-02-22

Lead Sponsor: Duke University

Target Recruit Count: 24

Registration Number: NCT00004604

Locations: 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States

Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer

Phase 1

Terminated

Conditions: Pancreatic Cancer

First Posted Date: 2004-04-27

Last Posted Date: 2014-02-10

Lead Sponsor: Duke University

Target Recruit Count: 8

Registration Number: NCT00003434

Locations: 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States

Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer

Phase 1

Completed

Conditions: Kidney Cancer

First Posted Date: 2004-03-23

Last Posted Date: 2013-03-20

Lead Sponsor: Duke University

Target Recruit Count: 15

Registration Number: NCT00005816

Locations: 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States

Temozolomide in Treating Patients With Anaplastic Oligodendroglioma

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2004-03-12

Last Posted Date: 2013-06-20

Lead Sponsor: Duke University

Target Recruit Count: 60

Registration Number: NCT00003465

Locations: 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States

Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart Failure

Phase 2

Completed

Conditions: Depression
Heart Failure, Congestive
Chronic Heart Failure

Interventions: Drug: Placebo
Drug: Sertraline

First Posted Date: 2004-02-24

Last Posted Date: 2013-02-27

Lead Sponsor: Duke University

Target Recruit Count: 469

Registration Number: NCT00078286

Locations: 🇺🇸
Duke Medical Center, Durham, North Carolina, United States

Treatment of Obsessive Compulsive Disorder in Children

Phase 3

Completed

Conditions: Obsessive-Compulsive Disorder

Interventions: Drug: Serotonin reuptake inhibitors management
Behavioral: Cognitive behavioral therapy by a psychologist
Behavioral: Instructional cognitive behavioral therapy by a psychiatrist

First Posted Date: 2003-12-22

Last Posted Date: 2014-07-29

Lead Sponsor: Duke University

Target Recruit Count: 124

Registration Number: NCT00074815

Locations: 🇺🇸
University of Pennsylvania, The Center for the Treatment and Study of Anxiety, Philadelphia, Pennsylvania, United States
🇺🇸
Duke Child and Family Study Center, Durham, North Carolina, United States
🇺🇸
Rhode Island Hospital, Providence, Rhode Island, United States

Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas

Phase 1

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2003-09-25

Last Posted Date: 2013-02-18

Lead Sponsor: Duke University

Registration Number: NCT00003463

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States

Survival TRaining for ENhancing Total Health (STRENGTH)

Phase 2

Completed

Conditions: Breast Cancer
Depression
Weight Changes

Interventions: Dietary Supplement: Calcium-Rich Diet
Other: Exercise + Fruit & Vegetable, Low Fat + Calcium Diet

First Posted Date: 2003-09-11

Last Posted Date: 2017-12-19

Lead Sponsor: Duke University

Target Recruit Count: 39

Registration Number: NCT00068458

Locations: 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
🇺🇸
Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States
🇺🇸
Southeastern Medical Oncology Center, Goldsboro, North Carolina, United States

and more 1 locations

Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2003-08-20

Last Posted Date: 2013-06-20

Lead Sponsor: Duke University

Target Recruit Count: 50

Registration Number: NCT00003464

Locations: 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States

Telephone Enhancement Procedure for Continuing Care - 1

Phase 3

Completed

Conditions: Substance-Related Disorders

First Posted Date: 2003-08-13

Last Posted Date: 2017-01-12

Lead Sponsor: Duke University

Target Recruit Count: 339

Registration Number: NCT00067171

Locations: 🇺🇸
Julian F. Keith, Black Mountain, North Carolina, United States
🇺🇸
James Gilmore Jr. Treatment Center, Kalamazoo, Michigan, United States
🇺🇸
Walter B. Jones, ADATC, Greenville, North Carolina, United States

and more 1 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy